Protective antiviral antibody responses in a mouse model of influenza virus infection require TACI

Journal of Clinical Investigation

Volumn 121, Issue 10, 2011, Pages 3954-3964

  Wolf, Amaya I ^a   Mozdzanowska, Krystyna ^a   Quinn III, William J ^b   Metzgar, Michele ^a   Williams, Katie L ^a   Caton, Andrew J ^a   Meffre, Eric ^a,c   Bram, Richard J ^d   Erickson, Loren D ^e   Allman, David ^b   Cancro, Michael P ^b   Erikson, Jan ^a  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Mayo Clinic   (United States)

^e UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR; CD11B ANTIGEN; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR;

AIRWAY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY SECRETING CELL; ANTIBODY TITER; ARTICLE; BONE MARROW; CD8+ T LYMPHOCYTE; CELL COUNT; CELL KINETICS; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; HUMORAL IMMUNITY; INFECTION PREVENTION; INFECTION SENSITIVITY; INFLUENZA; IRRADIATION; LUNG ALVEOLUS CELL; LYMPH NODE; LYMPHOID ORGAN; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SECRETORY CELL; SIGNAL TRANSDUCTION; SPLEEN;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY-PRODUCING CELLS; B-CELL ACTIVATING FACTOR; CD8-POSITIVE T-LYMPHOCYTES; CELL SURVIVAL; DISEASE MODELS, ANIMAL; FEMALE; LUNG; MALE; MICE; MICE, INBRED C3H; MICE, KNOCKOUT; MICE, TRANSGENIC; ORTHOMYXOVIRIDAE INFECTIONS; SIGNAL TRANSDUCTION; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR PROTEIN; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13;

EID: 80053419938     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI57362     Document Type: Article

References (81)

1. Gerhard W. The role of the antibody response in influenza virus infection. Curr Top Microbiol Immunol. 2001;260:171-190. (Pubitemid 32574063)
2. Slifka MK, Antia R, Whitmire JK, Ahmed R. Humoral immunity due to long-lived plasma cells. Immunity. 1998;8(3):363-372. (Pubitemid 28188896)
3. Amanna IJ, Carlson NE, Slifka MK. Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med. 2007;357(19):1903-1915. (Pubitemid 350074686)
4. Dörner T, Radbruch A. Antibodies and B cell memory in viral immunity. Immunity. 2007;27(3):384-392. (Pubitemid 47418684)
5. Jones PD, Ada GL. Influenza virus-specific antibodysecreting cells in the murine lung during primary influenza virus infection. J Virol. 1986;60(2):614-619. (Pubitemid 17174902)
6. Joo HM, He Y, Sangster MY. Broad dispersion and lung localization of virus-specific memory B cells induced by influenza pneumonia. Proc Natl Acad Sci U S A. 2008;105(9):3485-3490. (Pubitemid 351723579)
7. Owens SL, Osebold JW, Zee YC. Dynamics of B-lymphocytes in the lungs of mice exposed to aerosolized influenza virus. Infect Immun. 1981;33(1):231-238. (Pubitemid 11066048)
8. Hyland L, Sangster M, Sealy R, Coleclough C. Respiratory virus infection of mice provokes a permanent humoral immune response. J Virol. 1994;68(9):6083-6086. (Pubitemid 24258630)
9. Jones PD, Ada GL. Persistence of influenza virusspecific antibody-secreting cells and B-cell memory after primary murine influenza virus infection. Cell Immunol. 1987;109(1):53-64. (Pubitemid 17155708)
10. Calame K. Transcription factors that regulate memory in humoral responses. Immunol Rev. 2006;211:269-279. (Pubitemid 43882978)
11. Kallies A, et al. Plasma cell ontogeny defined by quantitative changes in blimp-1 expression. J Exp Med. 2004;200(8):967-977. (Pubitemid 39431122)
12. Shapiro-Shelef M, Lin K-I, Savitsky D, Liao J, Calame K. Blimp-1 is required for maintenance of long-lived plasma cells in the bone marrow. J Exp Med. 2005;202(11):1471-1476. (Pubitemid 41746593)
13. Manz RA, Thiel A, Radbruch A. Lifetime of plasma cells in the bone marrow. Nature. 1997;388(6638):133-134. (Pubitemid 27297440)
14. O'Connor BP, Cascalho M, Noelle RJ. Short-lived and long-lived bone marrow plasma cells are derived from a novel precursor population. J Exp Med. 2002;195(6):737-745. (Pubitemid 34259718)
15. Slifka MK, Matloubian M, Ahmed R. Bone marrow is a major site of long-term antibody production after acute viral infection. J Virol. 1995;69(3):1895-1902.
16. Manz RA, Lohning M, Cassese G, Thiel A, Radbruch A. Survival of long-lived plasma cells is independent of antigen. Int Immunol. 1998;10(11):1703-1711. (Pubitemid 28502384)
17. Tarlinton D, Radbruch A, Hiepe F, Dorner T. Plasma cell differentiation and survival. Curr Opin Immunol. 2008;20(2):162-169.
18. Cassese G, et al. Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals. J Immunol. 2003;171(4):1684-1690. (Pubitemid 36966450)
19. Xiang Z, et al. FcgammaRIIb controls bone marrow plasma cell persistence and apoptosis. Nat Immunol. 2007;8(4):419-429. (Pubitemid 46745417)
20. Hargreaves DC, et al. A coordinated change in chemokine responsiveness guides plasma cell movements. J Exp Med. 2001;194(1):45-56. (Pubitemid 32660436)
21. Kunkel EJ, Butcher EC. Plasma-cell homing. Nat Rev Immunol. 2003;3(10):822-829. (Pubitemid 37328660)
22. Mackay F, Schneider P, Rennert P, Browning J. BAFF AND APRIL: a tutorial on B cell survival. Annu Rev Immunol. 2003;21:231-264. (Pubitemid 37174532)
23. Cancro MP. The BLyS family of ligands and receptors: an archetype for niche-specific homeostatic regulation. Immunol Rev. 2004;202:237-249. (Pubitemid 39576916)
24. Benson MJ, et al. Cutting edge: the dependence of plasma cells and independence of memory B cells on BAFF and APRIL. J Immunol. 2008;180(6):3655-3659.
25. O'Connor BP. BCMA is essential for the survival of long-lived bone marrow plasma cells. J Exp Med. 2003;199(1):91-98.
26. Huard B, et al. APRIL secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosa. J Clin Invest. 2008;118(8):2887-2895.
27. Kato A, Truong-Tran AQ, Scott AL, Matsumoto K, Schleimer RP. Airway epithelial cells produce B cell-activating factor of TNF family by an IFN-beta-dependent mechanism. J Immunol. 2006;177(10):7164-7172. (Pubitemid 44715085)
28. Xu W, et al. Viral double-stranded RNA triggers Ig class switching by activating upper respiratory mucosa B cells through an innate TLR3 pathway involving BAFF. J Immunol. 2008;181(1):276-287.
29. Katsenelson N, Kanswal S, Puig M, Mostowski H, Verthelyi D, Akkoyunlu M. Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion. Eur J Immunol. 2007;37(7):1785-1795. (Pubitemid 47065118)
30. Tezuka H, et al. Regulation of IgA production by naturally occurring TNF/iNOS-producing dendritic cells. Nature. 2007;448(7156):929-933. (Pubitemid 47312771)
31. Balázs M, Martin F, Zhou T, Kearney J. Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity. 2002;17(3):341-352. (Pubitemid 35279554)
32. MacLennan I, Vinuesa C. Dendritic cells, BAFF, and APRIL: innate players in adaptive antibody responses. Immunity. 2002;17(3):235-238. (Pubitemid 35279545)
33. Litinskiy MB, et al. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol. 2002;3(9):822-829.
34. Bessa J, et al. Alveolar macrophages and lung dendritic cells sense RNA and drive mucosal IgA responses. J Immunol. 2009;183(6):3788-3799.
35. Mohr E, et al. Dendritic cells and monocyte/macrophages that create the IL-6/APRIL-rich lymph node microenvironments where plasmablasts mature. J Immunol. 2009;182(4):2113-2123.
36. Stadanlick JE, et al. Tonic B cell antigen receptor signals supply an NF-kappaB substrate for prosurvival BLyS signaling. Nat Immunol. 2008;9(12):1379-1387.
37. Ng LG, et al. BAFF costimulation of Toll-like receptor-activated B-1 cells. Eur J Immunol. 2006;36(7):1837-1846. (Pubitemid 44089050)
38. Treml LS, Crowley JE, Cancro MP. BLyS receptor signatures resolve homeostatically independent compartments among naïve and antigen-experienced B cells. Semin Immunol. 2006;18(5):297-304. (Pubitemid 44382640)
39. Chang SK, Arendt BK, Darce JR, Wu X, Jelinek DF. A role for BLyS in the activation of innate immune cells. Blood. 2006;108(8):2687-2694.
40. Mackay F, Leung H. The role of the BAFF/APRIL system on T cell function. Semin Immunol. 2006;18(5):284-289. (Pubitemid 44287556)
41. Castigli E, Wilson SA, Elkhal A, Ozcan E, Garibyan L, Geha RS. Transmembrane activator and calcium modulator and cyclophilin ligand interactor enhances CD40-driven plasma cell differentiation. J Allergy Clin Immunol. 2007;120(4):885-891. (Pubitemid 47531843)
42. Castigli E, et al. TACI and BAFF-R mediate isotype switching in B cells. J Exp Med. 2005;201(1):35-39. (Pubitemid 40130081)
43. He B, et al. The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88. Nat Immunol. 2010;11(9):836-845.
44. Sakurai D, Kanno Y, Hase H, Kojima H, Okumura K, Kobata T. TACI attenuates antibody production costimulated by BAFF-R and CD40. Eur J Immunol. 2007;37(1):110-118. (Pubitemid 46128791)
45. Yan M, et al. Activation and accumulation of B cells in TACI-deficient mice. Nat Immunol. 2001;2(7):638-643. (Pubitemid 32677632)
46. Von Bülow GU, van Deursen JM, Bram RJ. Regulation of the T-independent humoral response by TACI. Immunity. 2001;14(5):573-582. (Pubitemid 32520868)
47. Mantchev GT, Cortesão CS, Rebrovich M, Cascalho M, Bram RJ. TACI is required for efficient plasma cell differentiation in response to T-independent type 2 antigens. J Immunol. 2007;179(4):2282-2288.
48. Ozcan E, Garibyan L, Lee JJ-Y, Bram RJ, Lam K-P, Geha RS. Transmembrane activator, calcium modulator, and cyclophilin ligand interactor drives plasma cell differentiation in LPS-activated B cells. J Allergy Clin Immunol. 2009;123(6):1277-1286.e1275.
49. Yan M, Marsters SA, Grewal IS, Wang H, Ashkenazi A, Dixit VM. Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity. Nat Immunol. 2000;1(1):37-41.
50. Yu G, et al. APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity. Nat Immunol. 2000;1(3):252-256.
51. Xia XZ, et al. TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation. J Exp Med. 2000;192(1):137-143.
52. Ingold K, et al. Identification of proteoglycans as the APRIL-specific binding partners. J Exp Med. 2005;201(9):1375-1383. (Pubitemid 40664082)
53. Rutishauser RL, et al. Transcriptional repressor Blimp-1 promotes CD8(+) T cell terminal differentiation and represses the acquisition of central memory T cell properties. Immunity. 2009;31(2):296-308.
54. Moyron-Quiroz JE, et al. Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat Med. 2004;10(9):927-934. (Pubitemid 39273733)
55. Gross JA, et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature. 2000;404(6781):995-999. (Pubitemid 30243593)
56. Scholz JL, et al. BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact. Proc Natl Acad Sci U S A. 2008;105(40):15517-15522.
57. Castigli E, et al. Impaired IgA class switching in APRIL-deficient mice. Proc Natl Acad Sci U S A. 2004;101(11):3903-3908. (Pubitemid 38381075)
58. Coro ES, Chang WLW, Baumgarth N. Type I IFN receptor signals directly stimulate local B cells early following influenza virus infection. J Immunol. 2006;176(7):4343-4351. (Pubitemid 44264414)
59. Sealy R, Surman S, Hurwitz JL, Coleclough C. Antibody response to influenza infection of mice: different patterns for glycoprotein and nucleocapsid antigens. Immunology. 2003;108(4):431-439. (Pubitemid 36469680)
60. Diaz-de-Durana Y, Mantchev GT, Bram RJ, Franco A. TACI-BLyS signaling via B-cell-dendritic cell cooperation is required for naive CD8+ T-cell priming in vivo. Blood. 2006;107(2):594-601. (Pubitemid 43076383)
61. Lee BO, et al. CD4 T cell-independent antibody response promotes resolution of primary influenza infection and helps to prevent reinfection. J Immunol. 2005;175(9):5827-5838. (Pubitemid 41508067)
62. Chang SK, Mihalcik SA, Jelinek DF. B lymphocyte stimulator regulates adaptive immune responses by directly promoting dendritic cell maturation. J Immunol. 2008;180(11):7394-7403.
63. Dienz O, et al. The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells. J Exp Med. 2009;206(1):69-78.
64. Scherle PA, Palladino G, Gerhard W. Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells. J Immunol. 1992;148(1):212-217.
65. Hardenberg G, van der Sluijs K, van der Poll T, Medema JP. APRIL affects antibody responses and early leukocyte infiltration, but not influenza A viral control. Mol Immunol. 2008;45(11):3050-3058.
66. Bossen C, et al. TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts. Blood. 2008;111(3):1004-1012. (Pubitemid 351213377)
67. Castigli E, et al. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet. 2005;37(8):829-834. (Pubitemid 41077108)
68. Salzer U, et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet. 2005;37(8):820-828. (Pubitemid 41077107)
69. Salzer U, et al. Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease- causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes. Blood. 2009;113(9):1967-1976.
70. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999;92(1):34-48. (Pubitemid 29315984)
71. Yamada T, et al. Poly(I:C) induces BLyS-expression of airway fibroblasts through phosphatidylinositol 3-kinase. Cytokine. 2010;50(2):163-169.
72. Dubois B, et al. Dendritic cells enhance growth and differentiation of CD40-activated B lymphocytes. J Exp Med. 1997;185(5):941-951. (Pubitemid 27119878)
73. Geurtsvankessel CH, et al. Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice. J Exp Med. 2009;206(11):2339-2349.
74. Chu VT, et al. Eosinophils are required for the maintenance of plasma cells in the bone marrow. Nat Immunol. 2011;12(2):151-159.
75. Gomez MR, Talke Y, Goebel N, Hermann F, Reich B, Mack M. Basophils support the survival of plasma cells in mice. J Immunol. 2010;185(12):7180-7185.
76. Mozdzanowska K, Maiese K, Furchner M, Gerhard W. Treatment of influenza virus-infected SCID mice with nonneutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduces the pulmonary virus titer but fails to clear the infection. Virology. 1999;254(1):138-146. (Pubitemid 29391721)
77. Mozdzanowska K, Furchner M, Washko G, Mozdzanowski J, Gerhard W. A pulmonary influenza virus infection in SCID mice can be cured by treatment with hemagglutinin-specific antibodies that display very low virus-neutralizing activity in vitro. J Virol. 1997;71(6):4347-4355. (Pubitemid 27204122)
78. Wolf AI, et al. Plasmacytoid dendritic cells are dispensable during primary influenza virus infection. J Immunol. 2009;182(2):871-879.
79. Mozdzanowska K, Maiese K, Gerhard W. Th cell-deficient mice control influenza virus infection more effectively than Th- and B cell-deficient mice: evidence for a Th-independent contribution by B cells to virus clearance. J Immunol. 2000;164(5):2635-2643. (Pubitemid 30115495)
80. User Bulletin #2: ABI PRISM 7700 Sequence Detection System. Foster City, California, USA: PerkinElmer Corp; 1997.
81. Liang S, Mozdzanowska K, Palladino G, Gerhard W. Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity. J Immunol. 1994;152(4):1653-1661. (Pubitemid 24075695)